Adaptive Biotechnologies Corporation (FWB:1HM) Financings

Adaptive Biotechnologies Corporation

Financings

RaiseDate
0% convertible senior notes due 2031
Made bigger: US$300M · J. Wood Capital Advisors LLC
Dealers: J. Wood Capital Advisors LLC
Use of proceeds: Capped call transactions, repurchase of $25 million of common stock, repayment of the OrbiMed Purchase Agreement, general corporate purposes and MRD initiatives
Jun 17, 2026

Read by 6ix AI from the company's releases